[Criteria of withdrawal of first-line DMT and substitution for second-line drugs (treatment escalation) basing on MRI results].
| Autor: | Krotenkova MV; Research Center of Neurology, Russian Academy of Sciences, Moscow., Morozova SN; Research Center of Neurology, Russian Academy of Sciences, Moscow., Briukhov VV; Research Center of Neurology, Russian Academy of Sciences, Moscow., Zavalishin IA; Research Center of Neurology, Russian Academy of Sciences, Moscow., Peresedova AV; Research Center of Neurology, Russian Academy of Sciences, Moscow. |
|---|---|
| Jazyk: | ruština |
| Zdroj: | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2015; Vol. 115 (2 Pt 2), pp. 79-80. |
| DOI: | 10.17116/jnevro20151152279-80 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|